Last reviewed · How we verify
Tricalm Hydrogel
Tricalm Hydrogel is a topical hydrogel formulation designed to provide localized delivery and sustained release of active pharmaceutical ingredients for dermatological or wound care applications.
Tricalm Hydrogel is a topical hydrogel formulation designed to provide localized delivery and sustained release of active pharmaceutical ingredients for dermatological or wound care applications. Used for Topical dermatological or wound care application (specific indication not publicly detailed).
At a glance
| Generic name | Tricalm Hydrogel |
|---|---|
| Also known as | TriCalm Steroid Free Soothing Itch Relief Hydrogel |
| Sponsor | University of California, San Diego |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
The hydrogel matrix allows for controlled release of therapeutic agents directly to affected skin or tissue areas, maintaining moisture and creating an optimal microenvironment for healing. This formulation approach reduces systemic exposure while maximizing local therapeutic concentration at the site of application.
Approved indications
- Topical dermatological or wound care application (specific indication not publicly detailed)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tricalm Hydrogel CI brief — competitive landscape report
- Tricalm Hydrogel updates RSS · CI watch RSS
- University of California, San Diego portfolio CI